newsfilter
← Latest News
GlobeNewswire·

Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients